'Zombie' companies already make up 11.5% of U.S. listed stocks
By Joy Wiltermuth
Investors should brace for more bankruptcies
About 11.5% of listed U.S. stocks already belong to a large network of "zombie" companies that have consistently earned less than they owe in interest costs, according to a tally from Glenmede.
While that might not sound ideal, higher bond yields or a recession could make a potentially ugly situation for investors even worse.
"The combination of rising borrowing costs and heightened recession risks could begin to tip zombie companies into bankruptcy," a team led by Jason Pride, chief of investment strategy and research at Glenmede, wrote in a Tuesday client note.
Stocks, unlike bonds, often are at risk of seeing their entire value wiped out if a company files for bankruptcy. Recessions also tend to shake out smaller and weaker companies with high debt loads, in part because funding from Wall Street can dry up.
The Glenmede strategy team arrived at their zombie figure by looking at the share of companies in the Russell 3000 index RUA whose earnings before interest, taxes, depreciation and amortization didn't meet their interest costs in the past three years.
While off peak levels in the wake of the pandemic, the chart suggests an elevated risk of public U.S. companies vulnerable to collapse.
The Russell 3000 index tracks shares of the largest 3,000 publicly traded companies, weighted by market capitalization, making it a proxy for the U.S. stock market, whereas the S&P 500 index SPX tracks the biggest 500 companies and the Dow Jones Industrial Average DJIA tracks 30 stocks.
Higher bond yields can ratchet up interest costs for companies that need to borrow or refinance maturing debt. The benchmark 10-year Treasury yield BX: TMUBMUSD10Y has now climbed for six straight months, closing out October at 4.874% and easing back from a brief jolt above 5%.
"All else equal, higher yields on Treasuries put pressure on equity markets,as future cash flows used to determine fair value are discounted at higher rates," the Glenmede team wrote.
Yields in the roughly $1.5 trillion high-yield, or "junk bond," market were last pegged near 9.4%, according to the ICE BofA US High Yield index, among the highest since 2009.
Yet the biggest junk-bond ETF, the iShares iBoxx $ High Yield Corporate Bond ETF HYG, was off only 1.4% on the year through Tuesday, according to FactSet.
Part of the resilience could be tied to the U.S. economy, which has continued to grow despite the Federal Reserve's aggressive pace of rate hikes since last year.
Also, while 11.5% of the Russell 3000 index was pegged as zombies, the group accounts for only 2.2% of the total value of the stock market, since many were small-cap companies, according to Glenmede.
Furthermore, not all zombies automatically look like an imminent risk, the Glenmede team said, because it folds in companies still finding a market for their products or services. It also can include small biotechnology and technology companies, which tend to follow a "proof of concept, then monetize" business model, they said.
Stocks ended higher Tuesday, but with the Dow Jones Industrial Average DJIA, S&P 500 index SPX and Nasdaq Composite Index COMP booking three straight months of declines, according to Dow Jones Market Data.
-Joy Wiltermuth
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-31-23 1739ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?